-
Sep 25, 2024 | 
self.com | Coral Olazagasti |Julia Sullivan
When 34-year-old Ashley Vassallo came down with a cough and chest pain in the fall of 2021, she assumed she had COVID. But Vassallo kept testing negative, so doctors started to think asthma, acid reflux, or even pneumonia was at play. Her health continued to worsen over a year-long period, eventually landing her in the ER, where a CT scan and biopsy revealed that Vassallo—an otherwise healthy, young, nonsmoker—had stage 4 lung cancer.
-
Jul 18, 2024 | 
onclive.com | Coral Olazagasti
CommentaryVideoJuly 18, 2024Author(s):Coral Olazagasti, MD, discusses disparities in lung cancer screening rates between Hispanic and non-Hispanic White survivors of head and neck cancer. Coral Olazagasti, MD, thoracic oncologist, professor, medicine, The University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, discusses factors that may contribute to disparities in lung cancer screening rates between Hispanic and non-Hispanic White survivors of head and neck cancer.
-
Jun 26, 2024 | 
onclive.com | Coral Olazagasti
Coral Olazagasti, MD, thoracic oncologist, professor, medicine, The University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, discusses the development of a tailored lung cancer screening program for Hispanic head and neck cancer survivors. This initiative addresses disparities in lung cancer outcomes and screening rates in this population.
-
May 24, 2024 | 
communitynewspapers.com | Coral Olazagasti |Arthi Sridhar |Miki Horiguchi |Claudia Villa Celi
Sylvester-led study presented at ASCO highlights biases reported by female cancer physiciansCoral Olazagasti expected a relatively smooth transition when she moved to New York to start her residency after graduating from medical school in her native Puerto Rico. But that proved wishful thinking. She not only experienced major culture shock, but also her superiors and colleagues often chastised her for speaking too loudly and joked about her accent.
-
Apr 17, 2024 | 
self.com | Coral Olazagasti |Julia Sullivan
If you have a vagina, you know things can ebb and flow (sometimes confusingly) in your lower region. Maybe you wake up with heinous cramps and wonder if your period is en route—or perhaps you just feel a little wonky, and you wonder if stress, a new prescription, or something else entirely, is to blame.
-
Mar 25, 2024 | 
self.com | Coral Olazagasti |Julia Sullivan
When a friend, family member, or public figure—most recently, Kate Middleton—says they’re going through chemotherapy, your mind might paint a pretty depressing picture. Perhaps you recount the images depicting cancer that you’ve seen in movies and shows—say, a person who’s very frail and ends up tearfully shaving their head. But while cancer is a scary concept, chemotherapy—the treatment that’s usually causing intense weakness, hair loss, and other side effects—really shouldn’t be.
-
Feb 8, 2024 | 
jamanetwork.com | Coral Olazagasti
The Threat of Florida’s New Legislation on Undocumented Individuals—A Call for Action For many, the United States is a renowned nation full of opportunity, as explicated by the moniker the “land of the free.”1 Yet, when we think of this phrase, we recognize that that this opportunity is a luxury that is mostly reserved for the privileged group.
-
Feb 3, 2024 | 
onclive.com | Coral Olazagasti
Coral Olazagasti, MD, assistant professor, Clinical Medical Oncology, Department of Medicine, Division of Medical Oncology, Sylvester Cancer Center, University of Miami Miller School of Medicine, discusses her participation in a case-based discussion at the 21st Annual Winter Lung Cancer Conference®, and the importance of having conversations such as these. During the event, Olazagasti presented a case study of a patient with non–small cell lung cancer (NSCLC) harboring an ALK alteration.
-
Nov 7, 2023 | 
pubs.rsna.org | Lecia V. Sequist |Coral Olazagasti
References1. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999;354(9173):99–105. Crossref, Medline, Google Scholar2. National Lung Screening Trial Research Team; Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365(5):395–409. Crossref, Medline, Google Scholar3.
-
Nov 2, 2023 | 
self.com | Sara Lindberg |Coral Olazagasti |Maggie O'Neill |Rozalynn Frazier
By SELF Staffers,Sara Lindberg,Medically reviewed by Coral Olazagasti, MD,Maggie O'Neill,Rozalynn S. Frazier, C.P.T.,Reviewed by Coral Olazagasti, MD,Tiffany Ayuda,Natasha Lavender,Jenna Ryu,Kayla Blanton,Serena Coady,Nina Bahadur,Jenny Singer,​Jessica Migala,Medically reviewed by Ryan Howes, PhD,Melissa Matthews,Carolyn L.
